A comprehensive view of regeneron pharmaceuticals inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Australia Patent: Regeneron Pharmaceuticals Files Application for 'COMPOSITIONS AND METHODS FOR REDUCING BIOBURDEN IN CHROMATOGRAPHY'
Published: December 08, 2023 by Australian Government
Australia: Regeneron Pharmaceuticals Receives Patent for 'Humanized model of kidney and liver disorders'
Published: December 08, 2023 by Australian Government
Australia Patent: REGENERON PHARMACEUTICALS Files Application for 'ANTI-TMPRSS6 ANTIBODIES AND USES THEREOF'
Published: December 08, 2023 by Australian Government
Patent Issued for Anti-NPR1 antibodies and uses thereof (USPTO 11820826)
Published: December 08, 2023 by NewsRx Hematology Daily
U.S. Patent and Trademark Office Releases Regeneron Pharmaceuticals's Patent Application for Rare Variants in Hematopoietic Stem Cells (HSC) and Hematopoietic Progenitor Cells (HPC) Associated with Somatic Alterations of the Blood
Published: December 07, 2023 by Pharmaceutical Patent News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count